Stay updated on Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-30T13:53:31.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The webpage has updated its date-related content, adding several future dates while removing some past dates.
    Difference
    0.3%
    Check dated 2025-04-23T08:24:27.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates regarding the study of zolbetuximab for gastric and gastroesophageal junction cancer, including detailed information on drug combinations, participant enrollment criteria, and study protocols. Key details about the treatment options and study design have been added, while extensive background information on zolbetuximab has been removed.
    Difference
    35%
    Check dated 2025-04-16T01:47:53.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 23, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.1%
    Check dated 2025-04-08T20:27:28.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.14.3) and a more recent last update date (2025-03-25).
    Difference
    0.1%
    Check dated 2025-04-01T17:29:50.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.4%
    Check dated 2025-03-03T22:20:02.000Z thumbnail image

Stay in the know with updates to Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.